Patrizia Giannatempo, Medical oncologist at Gemelli Polyclinic Foundation IRCCS, shared on X:
“Is this the end of the cisplatin eligibility era in MIBC? Our new Letter in European Urology.
A new perioperative era is opening.”
Title: Is This the End of the Cisplatin Eligibility Era in Muscle-invasive Bladder Cancer?
Authors: Patrizia Giannatempo, Linda Cerbone, Fabio Calabrò
You can also read:
Renal Function and Oncological Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer
